VANCOUVER, Nov. 2, 2018 /CNW/ - INVICTUS MD STRATEGIES
CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) today announced the completion of its previously
announced definitive agreement to acquire 100% (the "Acquisition") of the issued and outstanding shares of a company
("Leaf Wise") that operates medical clinics in Alberta (see press releases dated
July 20, 2018 and October 25, 2018 for more details). The Acquisition
was approved by the Board and TSXV on October 31, 2018.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman and CEO
Jessica Martin
Vice President, Public Relations and Regulatory Affairs
(833) 879-4363
About Invictus
Invictus is a global cannabis company offering a selection of products under a wide range of lifestyle brands. Our integrated
sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to
Licensed Producer and retail stores.
Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist Officer. To meet growing demand, Invictus is expanding its
cultivation footprint, with two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with
200,000 expected by January 2019 and up to 1 million by end of 2020. To accommodate international
sales, Invictus' wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has designed and is currently building its
Phase 3 and 4 purpose-built cultivation facilities to be European Union Good Manufacturing Practices ("EU-GMP") compliant. The
Company will earmark up to 50 per cent of production to the medical. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its subsidiary, Future Harvest Development Ltd., a high-quality Fertilizer
and Nutrients manufacturer. Invictus drives sustainable long-term shareholder value through a diversified product portfolio with
over 69 Health Canada approved strains and a multifaceted distribution strategy including medical, adult-use, international,
Licensed Producer to Licensed Producer and retail stores. For more information visit www.invictus-md.com.
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may
constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing,
assumptions or expectations of future performance, including the potential production capacity of Invictus, are forward-looking
statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by
the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements
that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on
certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this
press release, including that Invictus will be successful in reaching its potential production capacity, its production
facilities will be completed as anticipated, regulatory approval will be granted as anticipated, Invictus will reach full
production capacity on the timeline anticipated by the Company, and no unforeseen construction delays will be experienced.
These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or
implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to
vary, include, without limitation, Invictus will not be successful in reaching its potential production capacity, its production
facilities will not be completed as anticipated, and licenses or approvals being granted on terms or timelines that are
materially worse than expected by the Company. Although management of the Company has attempted to identify important factors
that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no
assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and
forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes.
The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that
are incorporated by reference herein, except in accordance with applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:http://www.prnewswire.com/news-releases/invictus-completes-leaf-wise-acquisition-300742924.html
SOURCE Invictus MD Strategies
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/02/c3928.html